Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02638766
Title	Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Acronym	REGISTRI
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Grupo Espanol de Investigacion en Sarcomas
Indications	gastrointestinal stromal tumor
Therapies	Regorafenib
Age Groups:	adult \| senior
Covered Countries	ITA \| FRA \| ESP